Guanidine

Guanidine

SCHEMBL15924672

N=C(N)N.NP(O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2

The experimentally established mechanism targets of Guanidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Guanidine SCHEMBL8391952 0.84
Guanidine SCHEMBL28034554 0.80
Guanidine SCHEMBL29983942 0.78
SCHEMBL16741 0.78
Guanidine SCHEMBL11330173 0.78
Guanidine SCHEMBL5613752 0.78
Guanidine SCHEMBL165720 0.78 NOS2 (0.42)
SCHEMBL3667891 0.78
Guanidine SCHEMBL2003 0.78
Guanidine SCHEMBL6306009 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2951191-B1 METHOD OF PREPARING OLIGOMERIC COMPOUNDS USING MODIFIED COUPLING PROTOCOLS IONIS PHARMACEUTICALS INC (US) 2018-10-17 EP disclosed
US-9701708-B2 Method of preparing oligomeric compounds using modified coupling protocols IONIS PHARMACEUTICALS, INC. (US) 2017-07-11 US disclosed
US-20150368288-A1 METHOD OF PREPARING OLIGOMERIC COMPOUNDS USING MODIFIED COUPLING PROTOCOLS ISIS PHARMACEUTICALS, INC. (US) 2015-12-24 US disclosed
EP-2951191-A2 METHOD OF PREPARING OLIGOMERIC COMPOUNDS USING MODIFIED COUPLING PROTOCOLS Isis Pharmaceuticals, Inc. (US) 2015-12-09 EP disclosed
WO-2014120861-A2 METHOD OF PREPARING OLIGOMERIC COMPOUNDS USING MODIFIED COUPLING PROTOCOLS ISIS PHARMACEUTICALS, INC. (US) 2014-08-07 WO disclosed